![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Crawford K Michelle Talbert Robert L
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.2, Iss.10, 2001-10, pp. : 1609-1613
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Primary and Secondary Stroke Prevention with Antiplatelet Drugs
Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Aspirin and Antiplatelet Agent Resistance: Implications for Prevention of Secondary Stroke
CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)